This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grisaru, D.
Right arrow Articles by Giladi, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grisaru, D.
Right arrow Articles by Giladi, M.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, May 2008, p. 1602-1605, Vol. 46, No. 5
0095-1137/08/$08.00+0     doi:10.1128/JCM.02483-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Pilot Study of Prevalence of High-Risk Human Papillomavirus Genotypes in Israeli Jewish Women Referred for Colposcopic Examination{triangledown}

Dan Grisaru,1,{dagger}* Boaz Avidor,2,{dagger} Jacob Niv,1 Silvia Marmor,3 Benjamin Almog,1 Cecilia Leibowitz,2 Merav Graidy,2 and Michael Giladi4

Department of Obstetrics and Gynecology,1 Laboratory for Viruses and Molecular Biology, The Bernard Pridan Laboratory for Molecular Biology of Infectious Diseases,2 The Infectious Disease Unit,4 Department of Pathology, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel3

Received 28 December 2007/ Returned for modification 14 February 2008/ Accepted 23 February 2008

The objective of the present study was to determine the prevalence of high-risk (HR) human papillomavirus (HPV) genotypes in a group of Israeli Jewish women referred for colposcopic examination. Scrape specimens were prospectively collected from 84 women referred for colposcopic examination. All the women underwent Papanicolaou (Pap) smears and colposcopies, and some also underwent cervical or loop electrosurgical excision procedure biopsy. HR HPV was detected in scrape specimens (Amplicor HPV test; Roche Molecular Systems), and the individual genotypes in these specimens were identified (HPV GenoArray test kit; Hybribio Ltd., Hong Kong). Forty-one (49%) specimens were positive by the Amplicor HPV test. Sixty-four samples (41 positive and 23 negative by the Amplicor HPV test) were also assayed by use of the HPV GenoArray kit. The overall level of agreement between the two assays was 93.8% (Cohen's kappa = 0.98). HR genotypes were found in 37/41 (90%) HPV-positive samples. The prevalences of the HR HPV genotypes in the 37 HPV-positive samples were 41% of patients for HPV type 16 (HPV-16), 22% for HPV-39, 19% for HPV-52, and 14% for HPV-18. Forty-one percent of these patients were infected with a single HR genotype, whereas 59% were infected with mixtures of HR genotypes. The presence of a relatively high percentage of HPV types 39 and 52 and the relatively high incidence of infections with mixtures of genotypes may be one of the reasons for the low rate of conversion from high-grade squamous intraepithelial lesions to invasive carcinoma in Israeli women. Larger and more comprehensive studies are warranted to investigate this issue in greater detail.


* Corresponding author. Mailing address: Gynecologic Oncology Service, Department of Obstetrics & Gynecology, Tel-Aviv Sourasky Medical Center, 6 Weizmann Street, Tel Aviv 64239, Israel. Phone: 972-3-9625622. Fax: 972-3-9625670. E-mail: grisaro{at}post.tau.ac.il

{triangledown} Published ahead of print on 5 March 2008.

{dagger} D. Grisaru and B. Avidor contributed equally to the paper.


Journal of Clinical Microbiology, May 2008, p. 1602-1605, Vol. 46, No. 5
0095-1137/08/$08.00+0     doi:10.1128/JCM.02483-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.